Lv3
220 积分 2024-03-14 加入
Bispecific antibodies: a mechanistic review of the pipeline
1个月前
已完结
Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases
2个月前
已完结
IL-1 pathways in inflammation and human diseases
2个月前
已完结
Preclinical characterization and clinical development of ILARIS® (canakinumab) for the treatment of autoinflammatory diseases
2个月前
已关闭
Issues in the Design and Interpretation of Chronic Toxicity and Carcinogenicity Studies in Rodents: Approaches to Dose Selection
2个月前
已完结
MF59™ as a vaccine adjuvant: a review of safety and immunogenicity
2个月前
已完结
A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older
2个月前
已完结
Of Mice and Not Men: Differences between Mouse and Human Immunology
2个月前
已完结
Safety and Immunogenicity of Nonadjuvanted and MF59-Adjuvanted Influenza A/H9N2 Vaccine Preparations
3个月前
已完结
Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®
3个月前
已完结
皖公网安备34019202002308
